Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Merck |
---|---|
Information provided by: | Merck |
ClinicalTrials.gov Identifier: | NCT00092300 |
The purpose of this study is to compare the safety and effectiveness of two approved drugs in the treatment of pain following dental surgery.
Condition | Intervention | Phase |
---|---|---|
Postoperative Pain |
Drug: MK0966, rofecoxib Drug: Comparator: valdecoxib |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | A Randomized, Double-Blind, Placebo- and Active-Comparator-Controlled, Single Dose Study of the Effect of Rofecoxib 50 mg and Valdecoxib 20 mg in Patients With Postoperative Dental Pain |
Estimated Enrollment: | 450 |
Study Start Date: | May 2002 |
The duration of treatment is 1 day.
Ages Eligible for Study: | 16 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | 2004_066 |
Study First Received: | September 22, 2004 |
Last Updated: | November 21, 2006 |
ClinicalTrials.gov Identifier: | NCT00092300 |
Health Authority: | United States: Food and Drug Administration |
dental surgery molar removal |
Signs and Symptoms Postoperative Complications Toothache Rofecoxib |
Pain Valdecoxib Pain, Postoperative |
Anti-Inflammatory Agents Molecular Mechanisms of Pharmacological Action Cyclooxygenase Inhibitors Physiological Effects of Drugs Enzyme Inhibitors Cyclooxygenase 2 Inhibitors Pharmacologic Actions Pathologic Processes |
Analgesics, Non-Narcotic Sensory System Agents Therapeutic Uses Anti-Inflammatory Agents, Non-Steroidal Analgesics Peripheral Nervous System Agents Antirheumatic Agents Central Nervous System Agents |